Dr. Adrian Banning

Biography

Adrian Banning is a professor specializing in Interventional Cardiology at the Radcliffe Department of Medicine. His research focuses on translational mechanisms of injury and reperfusion in ST elevation myocardial injury. He has significantly contributed to the understanding of Troponin elevation as a reflection of new myocardial injury, documented through MRI imaging. His work includes a randomized controlled trial comparing PCI to CABG and the analysis of biomarkers in myocardial injury published in the Journal of the American College of Cardiology in 2011. As a leading researcher in the field, he played a vital role in the clinical launch of drug-eluting stents (DES) across the UK and championed the use of intravascular ultrasound (IVUS), participating in landmark international studies such as Taxus Endeavour. His leadership in the Syntax trial established him as a prominent investigator, and he has published extensively, including a significant paper in the New England Journal of Medicine in 2017. His service development initiatives began in 1999, enhancing treatment programs for elective PCI. Banning's innovative service delivery has earned recognition and has been presented at national forums. He also contributes to the management of Aortic Stenosis and TAVI care guidelines as part of his involvement with the British Cardiovascular Society and the Royal College of Physicians.

Research Interests